Top

Published in:

01-09-2014 | Sine qua non Radiology-Pathology

Recurrent Pleomorphic Adenoma

Authors: Rachel L. Werner, James T. Castle

Published in: Head and Neck Pathology | Issue 3/2014

Excerpt

A 29-year-old male presented for evaluation of an enlarging 4.5 cm firm but mobile mass of the left cheek. He additionally desired revision for a scar that resulted from a prior surgical procedure wherein the patient described undergoing surgery 12 years earlier for a “cyst” in the same region of the face. The patient stated that the surgery was terminated mid-procedure due to concern for the surrounding salivary gland. …

Ellis GL, Auclair PL. Tumors of the Salivary Glands. Atlas of tumor pathology, 4th series, Fascicle 9, 1st ed. Washington, DC: Armed Forces Institute of Pathology; 2007.

Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg. 1986;8:177–84.PubMedCrossRef

Bogaert J, Hermans R, Baert AL. Pleomorphic adenoma of the parotid gland. J Belge Radiol. 1993;76:307–10.PubMed

Kakimoto N, Gamoh S, Tamaki J, et al. CT and MR images of pleomorphic adenoma in major and minor salivary glands. Eur J Radiol. 2009;69:464–72.PubMedCrossRef

Lee YY, Wong KT, King AD, et al. Imaging of salivary gland tumours. Eur J Radiol. 2008;66:419–36.PubMedCrossRef

Thompson LDR, Wenig BM. Diagnostic pathology: head and neck. Salt Lake City: Amirsys; 2011.

Tsushima Y, Matsumoto M, Endo K, et al. Characteristic bright signal of parotid pleomorphic adenomas on T2-weighted MR images with pathological correlation. Clin Radiol. 1994;49:485–9.PubMedCrossRef

Kashiwagi N, Murakami T, Chikugo T, et al. Carcinoma ex pleomorphic adenoma of the parotid gland. Acta Radiol. 2012;53:303–6.PubMedCrossRef

Koral K, Sayre J, Bhuta S, et al. Recurrent pleomorphic adenoma of the parotid gland in pediatric and adult patients: value of multiple lesions as a diagnostic indicator. AJR Am J Roentgenol. 2003;180:1171–4.PubMedCrossRef

10.

Lam KH, Wei WI, Ho HC, et al. Whole organ sectioning of mixed parotid tumors. Am J Surg. 1990;160:377–81.PubMedCrossRef

11.

Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005.

12.

Campbell WG Jr, Priest RE, Weathers DR. Characterization of two types of crystalloids in pleomorphic adenomas of minor salivary glands. A light-microscopic, electron-microscopic, and histochemical study. Am J Pathol. 1985;118:194–202.PubMedCentralPubMed

13.

Nagao T, Sato E, Inoue R, et al. Immunohistochemical analysis of salivary gland tumors: application for surgical pathology practice. Acta Histochem Cytochem. 2012;45:269–82.PubMedCentralPubMedCrossRef

14.

Dardick I, Ostrynski VL, Ekem JK, et al. Immunohistochemical and ultrastructural correlates of muscle-actin expression in pleomorphic adenomas and myoepitheliomas based on comparison of formalin and methanol fixation. Virchows Arch A Pathol Anat Histopathol. 1992;421:95–104.PubMedCrossRef

15.

Kas K, Voz ML, Röijer E, et al. Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleomorphic adenomas with t(3;8)(p21;q12) translocations. Nature Genet. 1997;15:170–4.PubMedCrossRef

16.

Hensen K, Van Valckenborgh IC, Kas K, et al. The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities. Cancer Res. 2002;62:1510–7.PubMed

17.

Aström AK, Voz ML, Röijer E, et al. Conserved mechanism of PLAG1 activation in salivary gland tumors with and without 8q12 abnormalities: identification of SII as a new fusion pleomorphic adenoma partner gene. Cancer Res. 1999;59:918–23.PubMed

18.

Voz ML, Aström AK, Kas K, et al. The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in upregulation of PLAG1 gene expression under control of the LIFR promoter. Oncogene. 1998;16:1409–16.PubMedCrossRef

19.

Martins C, Fonseca I, Roque L, et al. PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization, and immunohistochemistry. Mod Pathol. 2005;18:1048–55.PubMedCrossRef

20.

Henriksson G, Westrin KM, Carlsöö B, et al. Recurrent primary pleomorphic adenomas of salivary gland origin: intrasurgical rupture, histopathologic features, and pseudopodia. Cancer. 1998;82:617–20.PubMedCrossRef

21.

Suh MW, Hah JH, Kwon SK, et al. Clinical manifestations of recurrent parotid pleomorphic adenoma. Clin Exp Otorhinolaryngol. 2009;2:193–7.PubMedCentralPubMedCrossRef

22.

Becelli R, Morello R, Renzi G, et al. Recurrent pleomorphic adenoma of the parotid gland: role of neutron radiation therapy. J Craniofac Surg. 2012;23:e449–50.PubMedCrossRef

23.

Leverstein H, van der Wal JE, Tiwari RM, et al. Surgical management of 246 previously untreated pleomorphic adenomas of the parotid gland. Br J Surg. 1997;84:399–403.PubMedCrossRef

Title: Recurrent Pleomorphic Adenoma
Authors: Rachel L. Werner
James T. Castle
Publication date: 01-09-2014
Publisher: Springer US
Published in: Head and Neck Pathology / Issue 3/2014
Electronic ISSN: 1936-0568
DOI: https://doi.org/10.1007/s12105-013-0504-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Recurrent Pleomorphic Adenoma

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2014

Carcinoma Ex-Schneiderian Papilloma (Malignant Transformation): A Clinicopathologic and Immunophenotypic Study of 20 Cases Combined with a Comprehensive Review of the Literature

Basal Cell Carcinoma Metastatic to Parotid Gland

Secretory Myoepithelial Carcinoma: A Histologic and Molecular Survey and a Proposed Nomenclature for Mucin Producing Signet Ring Tumors

Intraoral Basal Cell Carcinoma, a Rare Neoplasm: Report of Three New Cases with Literature Review

Post-radiation Atypical Vascular Lesion/Angiosarcoma Arising in the Larynx

Ectomesenchymal Chondromyxoid Tumour of the Posterior Tongue